HK Stock MarketDetailed Quotes

01541 IMMUNEONCO-B

Watchlist
  • 13.860
  • -0.140-1.00%
Market Closed Jun 27 16:08 CST
5.19BMarket Cap-12386P/E (TTM)

IMMUNEONCO-B Key Stats

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
Turnover
-28.25%386K
--86K
-89.38%538K
325.44%5.07M
--1.19M
Operating income
-28.25%386K
86K
-89.38%538K
325.44%5.07M
1.19M
Operating expenses
Gross profit
Administrative expenses
13.33%-80.42M
---41.26M
-92.05%-92.8M
-216.60%-48.32M
---15.26M
Research and development expenses
-5.26%-291.94M
---128.09M
-57.62%-277.35M
-130.93%-175.95M
---76.19M
Special items of operating profit
81.68%-5.95M
---944K
93.66%-32.5M
10.04%-512.85M
---570.08M
Operating profit
6.01%-377.94M
-170.2M
45.07%-402.11M
-10.86%-732.06M
-660.35M
Financing cost
-93.65%-1.52M
---630K
11.67%-787K
-50.76%-891K
---591K
Earning before tax
5.82%-379.46M
-170.83M
45.03%-402.89M
-10.89%-732.95M
-660.94M
After-tax profit from continuing operations
5.82%-379.46M
-170.83M
45.03%-402.89M
-10.89%-732.95M
-660.94M
Earning after tax
5.82%-379.46M
-170.83M
45.03%-402.89M
-10.89%-732.95M
-660.94M
Profit attributable to shareholders
5.82%-379.46M
-170.83M
45.03%-402.89M
-10.89%-732.95M
-660.94M
Basic earnings per share
13.22%-1.05
-0.48
85.76%-1.21
-15.80%-8.5
-7.34
Diluted earnings per share
13.22%-1.05
-0.48
85.76%-1.21
-15.80%-8.5
-7.34
Currency Unit
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Auditor
Deloitte & Touche Tohmatsu Certified Public Accountants
--
Deloitte & Touche Tohmatsu Certified Public Accountants
Deloitte & Touche Tohmatsu Certified Public Accountants
Deloitte & Touche Tohmatsu Certified Public Accountants
(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020
Turnover -28.25%386K--86K-89.38%538K325.44%5.07M--1.19M
Operating income -28.25%386K86K-89.38%538K325.44%5.07M1.19M
Operating expenses
Gross profit
Administrative expenses 13.33%-80.42M---41.26M-92.05%-92.8M-216.60%-48.32M---15.26M
Research and development expenses -5.26%-291.94M---128.09M-57.62%-277.35M-130.93%-175.95M---76.19M
Special items of operating profit 81.68%-5.95M---944K93.66%-32.5M10.04%-512.85M---570.08M
Operating profit 6.01%-377.94M-170.2M45.07%-402.11M-10.86%-732.06M-660.35M
Financing cost -93.65%-1.52M---630K11.67%-787K-50.76%-891K---591K
Earning before tax 5.82%-379.46M-170.83M45.03%-402.89M-10.89%-732.95M-660.94M
After-tax profit from continuing operations 5.82%-379.46M-170.83M45.03%-402.89M-10.89%-732.95M-660.94M
Earning after tax 5.82%-379.46M-170.83M45.03%-402.89M-10.89%-732.95M-660.94M
Profit attributable to shareholders 5.82%-379.46M-170.83M45.03%-402.89M-10.89%-732.95M-660.94M
Basic earnings per share 13.22%-1.05-0.4885.76%-1.21-15.80%-8.5-7.34
Diluted earnings per share 13.22%-1.05-0.4885.76%-1.21-15.80%-8.5-7.34
Currency Unit CNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIAS
Audit Opinions Unqualified Opinion--Unqualified OpinionUnqualified OpinionUnqualified Opinion
Auditor Deloitte & Touche Tohmatsu Certified Public Accountants--Deloitte & Touche Tohmatsu Certified Public AccountantsDeloitte & Touche Tohmatsu Certified Public AccountantsDeloitte & Touche Tohmatsu Certified Public Accountants

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg